{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:10:31Z","timestamp":1759936231464,"version":"3.37.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["CSD2010-00065","CTQ2017-90852-REDC"],"award-info":[{"award-number":["CSD2010-00065","CTQ2017-90852-REDC"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Regional Development Fundings"},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["Prometeo 2015\/002"],"award-info":[{"award-number":["Prometeo 2015\/002"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universitat de Valencia","award":["UV-INV-AE 15-332846"],"award-info":[{"award-number":["UV-INV-AE 15-332846"]}]},{"name":"Ministerio de Educaci\u00f3n","award":["FPU14\/01537"],"award-info":[{"award-number":["FPU14\/01537"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00436-020-06779-0","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T01:45:27Z","timestamp":1593567927000},"page":"2943-2954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition"],"prefix":"10.1007","volume":"119","author":[{"given":"Rub\u00e9n","family":"Mart\u00edn-Escolano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Mart\u00edn-Escolano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ballesteros-Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Cirauqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Abarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"S\u00e1nchez-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-2742","authenticated-orcid":false,"given":"Clotilde","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"6779_CR1","doi-asserted-by":"publisher","first-page":"e02288","DOI":"10.1128\/AAC.02288-16","volume":"61","author":"M\u00c1 Abeng\u00f3zar","year":"2017","unstructured":"Abeng\u00f3zar M\u00c1, Cebri\u00e1n R, Saugar JM et al (2017) Enterocin AS-48 AS evidence for the use of bacteriocins as new leishmanicidal agents. Antimicrob Agents Chemother 61:e02288\u2013e02216","journal-title":"Antimicrob Agents Chemother"},{"key":"6779_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jac\/dkx516","volume":"73","author":"E Aldasoro","year":"2018","unstructured":"Aldasoro E, Posada E, Requena-M\u00e9ndez A, Calvo-Cano A, Serret N, Casellas A, Sanz S, Soy D, Pinazo MJ, Gascon J (2018) What to expect and when: benznidazole toxicity in chronic Chagas\u2019 disease treatment. J Antimicrob Chemother 73:1060\u20131067","journal-title":"J Antimicrob Chemother"},{"key":"6779_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","volume":"4","author":"KT Andrews","year":"2014","unstructured":"Andrews KT, Fisher G, Skinner-Adams TS (2014) Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist 4:95\u2013111","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"6779_CR4","doi-asserted-by":"crossref","unstructured":"Bastos CJC, Aras R, Mota G, et al (2010) Clinical outcomes of thirteen patients with acute Chagas disease acquired through oral transmission from two urban outbreaks in Northeastern Brazil 4:16\u201317","DOI":"10.1371\/journal.pntd.0000711"},{"key":"6779_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2174\/0929867323666161227094049","volume":"24","author":"I Beltr\u00e1n-Hortelano","year":"2017","unstructured":"Beltr\u00e1n-Hortelano I, P\u00e9rez-Silanes S, Galiano S (2017) Trypanothione reductase and superoxide dismutase as current drug targets for Trypanosoma cruzi: an overview of compounds with activity against Chagas disease. Curr Med Chem 24:1066\u20131138","journal-title":"Curr Med Chem"},{"key":"6779_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1056\/NEJMra1410150","volume":"373","author":"C Bern","year":"2015","unstructured":"Bern C (2015) Chagas\u2019 disease. N Engl J Med 373:456\u2013466","journal-title":"N Engl J Med"},{"key":"6779_CR7","doi-asserted-by":"crossref","unstructured":"Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States 30341:52\u201354","DOI":"10.1086\/605091"},{"key":"6779_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/CMR.00005-11","volume":"24","author":"C Bern","year":"2011","unstructured":"Bern C, Kjos S, Yabsley MJ, Montgomery SP (2011) Trypanosoma cruzi and chagas\u2019 disease in the United States. Clin Microbiol Rev 24:655\u2013681","journal-title":"Clin Microbiol Rev"},{"key":"6779_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0003-2697(87)90489-1","volume":"161","author":"WF Beyer","year":"1987","unstructured":"Beyer WF, Fridovich I (1987) Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem 161:559\u2013566","journal-title":"Anal Biochem"},{"key":"6779_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.meegid.2014.10.004","volume":"28","author":"D Blanchet","year":"2014","unstructured":"Blanchet D, Fr\u00e9d\u00e9rique S, Schijman AG et al (2014) Infection, genetics and evolution first report of a family outbreak of Chagas disease in French Guiana and posttreatment follow-up. Infect Genet Evol 28:245\u2013250","journal-title":"Infect Genet Evol"},{"key":"6779_CR11","doi-asserted-by":"crossref","unstructured":"Bower JD, Gramage GR (1957) Heterocyclic systems related to pyrrocoline. Part II. The preparation of polyazaindenes by dehydrogenative cyclisations. J Chem Soc:4506\u20134510","DOI":"10.1039\/jr9570004506"},{"key":"6779_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"6779_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molbiopara.2006.03.017","volume":"149","author":"F Bringaud","year":"2006","unstructured":"Bringaud F, Rivi\u00e8re L, Coustou V (2006) Energy metabolism of trypanosomatids: adaptation to available carbon sources. Mol Biochem Parasitol 149:1\u20139","journal-title":"Mol Biochem Parasitol"},{"key":"6779_CR14","doi-asserted-by":"publisher","first-page":"ftv082","DOI":"10.1093\/femspd\/ftv082","volume":"73","author":"F Cardillo","year":"2015","unstructured":"Cardillo F, Teixeira Pinho R, Zuquim Antas PR, Mengel J (2015) Immunity and immune modulation in Trypanosoma cruzi infection. Pathog Dis 73:ftv082","journal-title":"Pathog Dis"},{"key":"6779_CR15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1191\/0960327106het653oa","volume":"25","author":"JA Castro","year":"2006","unstructured":"Castro JA, de Mecca MM, Bartel LC (2006) Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis). Hum Exp Toxicol 25:471\u2013479","journal-title":"Hum Exp Toxicol"},{"key":"6779_CR16","doi-asserted-by":"publisher","first-page":"683230","DOI":"10.1155\/2014\/683230","volume":"2014","author":"E Cunha-Neto","year":"2014","unstructured":"Cunha-Neto E, Chevillard C (2014) Chagas disease cardiomyopathy: immunopathology and genetics. Mediat Inflamm 2014:683230","journal-title":"Mediat Inflamm"},{"key":"6779_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1099\/00221287-44-2-149","volume":"44","author":"RH De Deken","year":"1966","unstructured":"De Deken RH (1966) The Crabtree effect: a regulatory system in yeast. J Gen Microbiol 44:149\u2013156","journal-title":"J Gen Microbiol"},{"key":"6779_CR18","unstructured":"DNDi (2019) https:\/\/www.dndi.org\/diseases-projects\/chagas\/%20chagas-target-product-profile\/. Accessed 12\/10\/2019"},{"key":"6779_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/nar\/gkm276","volume":"35","author":"TJ Dolinsky","year":"2007","unstructured":"Dolinsky TJ, Czodrowski P, Li H et al (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35:522\u2013525","journal-title":"Nucleic Acids Res"},{"key":"6779_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1017\/S003118201300142X","volume":"141","author":"R Don","year":"2014","unstructured":"Don R, Ioset JR (2014) Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections. Parasitology 141:140\u2013146","journal-title":"Parasitology"},{"key":"6779_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1550-7408.1997.tb05734.x","volume":"44","author":"C Fern\u00e1ndez-Becerra","year":"1997","unstructured":"Fern\u00e1ndez-Becerra C, Sanchez-Moreno M, Osuna A, Opperdoes FR (1997) Comparative aspects of energy metabolism in plant Trypanosomatids. J Eukaryot Microbiol 44:523\u2013529","journal-title":"J Eukaryot Microbiol"},{"key":"6779_CR22","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.2174\/0929867322666151015120804","volume":"22","author":"L Gaspar","year":"2015","unstructured":"Gaspar L, Moraes C, Freitas-Junior L, Ferrari S, Costantino L, Costi M, Coron R, Smith T, Siqueira-Neto J, McKerrow J, Cordeiro-da-Silva A (2015) Current and future chemotherapy for Chagas disease. Curr Med Chem 22:4293\u20134312","journal-title":"Curr Med Chem"},{"key":"6779_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1021\/jm031150y","volume":"48","author":"N Germonprez","year":"2005","unstructured":"Germonprez N, Maes L, Van Puyvelde L et al (2005) In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives. J Med Chem 48:32\u201337","journal-title":"J Med Chem"},{"key":"6779_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/AAC.05135-11","volume":"56","author":"BS Hall","year":"2012","unstructured":"Hall BS, Wilkinson SR (2012) Activation of benznidazole by Trypanosomal type I nitroreductases results in glyoxal formation. Antimicrob Agents Chemother 56:115\u2013123","journal-title":"Antimicrob Agents Chemother"},{"key":"6779_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR (2012) Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 4:17","journal-title":"J Cheminform"},{"key":"6779_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/B978-0-12-398457-9.00006-8","volume":"79","author":"K Hashimoto","year":"2012","unstructured":"Hashimoto K, Yoshioka K (2012) Review: surveillance of Chagas disease. Adv Parasitol 79:375\u2013428","journal-title":"Adv Parasitol"},{"key":"6779_CR27","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/infdis\/jiw360","volume":"214","author":"C Hern\u00e1ndez","year":"2016","unstructured":"Hern\u00e1ndez C, Vera MJ, Cucunub\u00e1 Z, Fl\u00f3rez C, Cantillo O, Buitrago LS, Gonz\u00e1lez MS, Ardila S, Due\u00f1as LZ, Tovar R, Forero LF, Ram\u00edrez JD (2016) High-resolution molecular typing of two large outbreaks of acute Chagas disease in Colombia. J Infect Dis Adv 214:1252\u20131255","journal-title":"J Infect Dis Adv"},{"key":"6779_CR28","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/jcc.20634","volume":"28","author":"R Huey","year":"2007","unstructured":"Huey R, Morris GM, Olson AJ, Goodsell DS (2007) Software news and update a semiempirical free energy force field with charge-based desolvation. J Comput Chem 28:1145\u20131152","journal-title":"J Comput Chem"},{"key":"6779_CR29","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1002\/j.1460-2075.1990.tb07462.x","volume":"9","author":"G Kendall","year":"1990","unstructured":"Kendall G, Wilderspin AF, Ashall F, Miles MA, Kelly JM (1990) Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the \u201chotspot\u201d topogenic signal model. EMBO J 9:2751\u20132758","journal-title":"EMBO J"},{"key":"6779_CR30","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/mmi.13653","volume":"104","author":"RL Kessler","year":"2017","unstructured":"Kessler RL, Contreras VT, Marli\u00e9re NP, Aparecida Guarneri A, Villamizar Silva LH, Mazzarotto GACA, Batista M, Soccol VT, Krieger MA, Probst CM (2017) Recently differentiated epimastigotes from Trypanosoma cruzi are infective to the mammalian host. Mol Microbiol 104:712\u2013736","journal-title":"Mol Microbiol"},{"key":"6779_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1006\/scdb.2001.0282","volume":"12","author":"IG Kirkinezos","year":"2001","unstructured":"Kirkinezos IG, Moraes CT (2001) Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 12:449\u2013457","journal-title":"Semin Cell Dev Biol"},{"key":"6779_CR32","first-page":"3","volume":"16","author":"B L.","year":"2011","unstructured":"L. B, J. M J, Y. C et al (2011) Chagas disease in european countries: the challenge of a surveillance system. Eurosurveillance 16:3","journal-title":"Eurosurveillance"},{"key":"6779_CR33","doi-asserted-by":"publisher","first-page":"C195","DOI":"10.1152\/ajpcell.00641.2005","volume":"291","author":"W Lee","year":"2006","unstructured":"Lee W, Th\u00e9venod F (2006) A role for mitochondrial aquaporins in cellular life-and-death decisions? AJP Cell Physiol 291:C195\u2013C202","journal-title":"AJP Cell Physiol"},{"key":"6779_CR34","first-page":"914129","volume":"2012","author":"\u00c1 L\u00f3pez-C\u00e9spedes","year":"2011","unstructured":"L\u00f3pez-C\u00e9spedes \u00c1, Villagr\u00e1n E, Brice\u00f1o \u00c1lvarez K et al (2011) Trypanosoma cruzi: seroprevalence detection in suburban population of Santiago de Quer\u00e9taro (Mexico). Sci World J 2012:914129","journal-title":"Sci World J"},{"key":"6779_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1128\/AAC.48.1.130-136.2004","volume":"48","author":"L Maes","year":"2004","unstructured":"Maes L, Vanden Berghe D, Germonprez N et al (2004) In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species. Antimicrob Agents Chemother 48:130\u2013136","journal-title":"Antimicrob Agents Chemother"},{"key":"6779_CR36","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1021\/acs.jmedchem.8b00468","volume":"61","author":"R Mart\u00edn-Escolano","year":"2018","unstructured":"Mart\u00edn-Escolano R, Moreno-Viguri E, Santivanez-Veliz M et al (2018) Second generation of Mannich base-type derivatives with in vivo activity against Trypanosoma cruzi. J Med Chem 61:5643\u20135663","journal-title":"J Med Chem"},{"key":"6779_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpddr.2019.03.003","volume":"10","author":"R Mart\u00edn-Escolano","year":"2019","unstructured":"Mart\u00edn-Escolano R, Cebri\u00e1n R, Mart\u00edn-Escolano J, Rosales MJ, Maqueda M, S\u00e1nchez-Moreno M, Mar\u00edn C (2019a) Insights into Chagas treatment based on the potential of bacteriocin AS-48. IJP Drugs Drug Resist 10:1\u20138","journal-title":"IJP Drugs Drug Resist"},{"key":"6779_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bmc.2019.01.033","volume":"27","author":"R Mart\u00edn-Escolano","year":"2019","unstructured":"Mart\u00edn-Escolano R, Mar\u00edn C, Vega M, Martin-Montes \u00c1, Medina-Carmona E, L\u00f3pez C, Rotger C, Costa A, S\u00e1nchez-Moreno M (2019b) Synthesis and biological evaluation of new long-chain squaramides as anti-chagasic agents in the BALB\/c mouse model. Bioorganic Med Chem 27:865\u2013879","journal-title":"Bioorganic Med Chem"},{"key":"6779_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejmech.2018.12.034","volume":"164","author":"R Mart\u00edn-Escolano","year":"2019","unstructured":"Mart\u00edn-Escolano R, Molina-Carre\u00f1o D, Delgado-Pinar E, Martin-Montes \u00c1, Clares MP, Medina-Carmona E, Pitarch-Jarque J, Mart\u00edn-Escolano J, Rosales MJ, Garc\u00eda-Espa\u00f1a E, S\u00e1nchez-Moreno M, Mar\u00edn C (2019c) New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases. Eur J Med Chem 164:27\u201346","journal-title":"Eur J Med Chem"},{"key":"6779_CR40","doi-asserted-by":"publisher","first-page":"12760","DOI":"10.1074\/jbc.M113.545590","volume":"289","author":"A Martinez","year":"2014","unstructured":"Martinez A, Peluffo G, Petruk AA, Hugo M, Pi\u00f1eyro D, Demicheli V, Moreno DM, Lima A, Batthy\u00e1ny C, Dur\u00e1n R, Robello C, Mart\u00ed MA, Larrieux N, Buschiazzo A, Trujillo M, Radi R, Piacenza L (2014) Structural and molecular basis of the peroxynitrite-mediated nitration and inactivation of Trypanosoma cruzi iron-superoxide dismutases (FE-SODs) A and B : disparate susceptibilities due to the repair of Tyr35 radical by Cys83 in FE-SODB through intramolecular electron transfer. J Biol Chem 289:12760\u201312778","journal-title":"J Biol Chem"},{"key":"6779_CR41","doi-asserted-by":"publisher","first-page":"15715","DOI":"10.1039\/C7RA01070B","volume":"7","author":"\u00c1 Mart\u00edn-Montes","year":"2017","unstructured":"Mart\u00edn-Montes \u00c1, Ballesteros-Garrido R, Mart\u00edn-Escolano R, Mar\u00edn C, Guiti\u00e9rrez-S\u00e1nchez R, Abarca B, Ballesteros R, Sanchez-Moreno M (2017) Synthesis and in vitro leishmanicidal activity of novel [1,2,3]triazolo[1,5-a]pyridine salts. RSC Adv 7:15715\u201315726","journal-title":"RSC Adv"},{"key":"6779_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bse0510015","volume":"51","author":"DA Maugeri","year":"2011","unstructured":"Maugeri DA, Cannata JJB, Cazzulo JJ (2011) Glucose metabolism in Trypanosoma cruzi. Essays Biochem 51:15\u201330","journal-title":"Essays Biochem"},{"key":"6779_CR43","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/infdis\/jis331","volume":"206","author":"AM Mejia","year":"2012","unstructured":"Mejia AM, Hall BS, Taylor MC, G\u00f3mez-Palacio A, Wilkinson SR, Triana-Ch\u00e1vez O, Kelly JM (2012) Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population. J Infect Dis 206:220\u2013228","journal-title":"J Infect Dis"},{"key":"6779_CR44","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.bbamcr.2006.08.019","volume":"1763","author":"PAM Michels","year":"2006","unstructured":"Michels PAM, Bringaud F, Herman M, Hannaert V (2006) Metabolic functions of glycosomes in trypanosomatids. Biochim Biophys Acta - Mol Cell Res 1763:1463\u20131477","journal-title":"Biochim Biophys Acta - Mol Cell Res"},{"key":"6779_CR45","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","volume":"370","author":"I Molina","year":"2014","unstructured":"Molina I, G\u00f3mez i Prat J, Salvador F, Trevi\u00f1o B, Sulleiro E, Serre N, Pou D, Roure S, Cabezos J, Valerio L, Blanco-Grau A, S\u00e1nchez-Montalv\u00e1 A, Vidal X, Pahissa A (2014) Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease. N Engl J Med 370:1899\u20131908","journal-title":"N Engl J Med"},{"key":"6779_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","volume":"104","author":"\u00c1 Moncayo","year":"2009","unstructured":"Moncayo \u00c1, Silveira AC (2009) Current epidemiological trends of Chagas disease in Latin America and future challenges in epidemiology, surveillance, and health policy. Mem Inst Oswaldo Cruz 104:17\u201330","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6779_CR47","doi-asserted-by":"publisher","first-page":"10929","DOI":"10.1021\/acs.jmedchem.6b00784","volume":"59","author":"E Moreno-Viguri","year":"2016","unstructured":"Moreno-Viguri E, Jim\u00e9nez-Montes C, Mart\u00edn-Escolano R, Santiva\u00f1ez-Veliz M, Martin-Montes A, Azqueta A, Jimenez-Lopez M, Zamora Ledesma S, Cirauqui N, L\u00f3pez de Cer\u00e1in A, Mar\u00edn C, S\u00e1nchez-Moreno M, P\u00e9rez-Silanes S (2016) In vitro and in vivo anti-Trypanosoma cruzi activity of new arylamine Mannich base-type derivatives. J Med Chem 59:10929\u201310945","journal-title":"J Med Chem"},{"key":"6779_CR48","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","volume":"373","author":"CA Morillo","year":"2015","unstructured":"Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velazquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, BENEFIT Investigators (2015) Randomized trial of Benznidazole for chronic Chagas\u2019 cardiomyopathy. N Engl J Med 373:1295\u20131306","journal-title":"N Engl J Med"},{"key":"6779_CR49","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","volume":"69","author":"CA Morillo","year":"2017","unstructured":"Morillo CA, Waskin H, Sosa-Estani S, del Carmen Bangher M, Cuneo C, Milesi R, Mallagray M, Apt W, Beloscar J, Gascon J, Molina I, Echeverria LE, Colombo H, Perez-Molina JA, Wyss F, Meeks B, Bonilla LR, Gao P, Wei B, McCarthy M, Yusuf S, STOP-CHAGAS Investigators (2017) Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzic: the STOP-CHAGAS Trial. J Am Coll Cardiol 69:939\u2013947","journal-title":"J Am Coll Cardiol"},{"key":"6779_CR50","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2010","unstructured":"Morris GM, Huey R, Lindstrom W et al (2010) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"6779_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1110\/ps.04979505","volume":"14","author":"IG Mu\u00f1oz","year":"2009","unstructured":"Mu\u00f1oz IG, Moran JF, Becana M, Montoya G (2009) The crystal structure of an eukaryotic iron superoxide dismutase suggests intersubunit cooperation during catalysis. Protein Sci 14:387\u2013394","journal-title":"Protein Sci"},{"key":"6779_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001412","volume":"5","author":"S Nwaka","year":"2011","unstructured":"Nwaka S, Besson D, Ramirez B, Maes L, Matheeussen A, Bickle Q, Mansour NR, Yousif F, Townson S, Gokool S, Cho-Ngwa F, Samje M, Misra-Bhattacharya S, Murthy PK, Fakorede F, Paris JM, Yeates C, Ridley R, van Voorhis WC, Geary T (2011) Integrated dataset of screening hits against multiple neglected disease pathogens. PLoS Negl Trop Dis 5:e1412","journal-title":"PLoS Negl Trop Dis"},{"key":"6779_CR53","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ejmech.2018.12.005","volume":"163","author":"R Paucar","year":"2019","unstructured":"Paucar R, Mart\u00edn-Escolano R, Moreno-Viguri E, Cirauqui N, Rodrigues CR, Mar\u00edn C, S\u00e1nchez-Moreno M, P\u00e9rez-Silanes S, Ravera M, Gabano E (2019) A step towards development of promising trypanocidal agents: synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives. Eur J Med Chem 163:569\u2013582","journal-title":"Eur J Med Chem"},{"key":"6779_CR54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","volume":"391","author":"JA P\u00e9rez-Molina","year":"2018","unstructured":"P\u00e9rez-Molina JA, Molina I (2018) Chagas disease. Lancet 391:82\u201394","journal-title":"Lancet"},{"key":"6779_CR55","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11908-012-0259-3","volume":"14","author":"JA P\u00e9rez-Molina","year":"2012","unstructured":"P\u00e9rez-Molina JA, Norman F, L\u00f3pez-V\u00e9lez R (2012) Chagas disease in non-endemic countries: epidemiology, clinical presentation and treatment. Curr Infect Dis Rep 14:263\u2013274","journal-title":"Curr Infect Dis Rep"},{"key":"6779_CR56","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF chimera - a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612","journal-title":"J Comput Chem"},{"key":"6779_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1472-6750-12-73","volume":"12","author":"G Pless-Petig","year":"2012","unstructured":"Pless-Petig G, Metzenmacher M, T\u00fcrk TR, Rauen U (2012) Aggravation of cold-induced injury in Vero-B4 cells by RPMI 1640 medium - identification of the responsible medium components. BMC Biotechnol 12:73","journal-title":"BMC Biotechnol"},{"key":"6779_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003540","volume":"9","author":"A Requena-M\u00e9ndez","year":"2015","unstructured":"Requena-M\u00e9ndez A, Aldasoro E, de Lazzari E, Sicuri E, Brown M, Moore DAJ, Gascon J, Mu\u00f1oz J (2015) Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis. PLoS Negl Trop Dis 9:e0003540","journal-title":"PLoS Negl Trop Dis"},{"key":"6779_CR59","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nrcardio.2012.109","volume":"9","author":"AL Ribeiro","year":"2012","unstructured":"Ribeiro AL, Maria P, Teixeira MM, Rocha MOC (2012) Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol 9:576\u2013589","journal-title":"Nat Rev Cardiol"},{"key":"6779_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093936","volume":"9","author":"JM Sandes","year":"2014","unstructured":"Sandes JM, Fontes A, Regis-da-Silva CG, de Castro MCAB, Lima-Junior CG, Silva FPL, Vasconcellos MLAA, Figueiredo RCBQ (2014) Trypanosoma cruzi cell death induced by the Morita-Baylis-Hillman adduct 3-hydroxy-2-methylene-3-(4-Nitrophenylpropanenitrile). PLoS One 9:e93936","journal-title":"PLoS One"},{"key":"6779_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.exppara.2004.07.001","volume":"108","author":"D Sereno","year":"2004","unstructured":"Sereno D, Tibayrenc M, Villarreal D, Barnabe C (2004) Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi , the agent of Chagas disease. Exp Parasitol 108:24\u201331","journal-title":"Exp Parasitol"},{"key":"6779_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00281-015-0481-9","volume":"37","author":"RL Tarleton","year":"2015","unstructured":"Tarleton RL (2015) CD8+ T cells in Trypanosoma cruzi infection. Semin Immunopathol 37:233\u2013238","journal-title":"Semin Immunopathol"},{"key":"6779_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.actatropica.2008.08.006","volume":"108","author":"J T\u00e9llez-Meneses","year":"2008","unstructured":"T\u00e9llez-Meneses J, Mej\u00eda-Jaramillo AM, Triana-Ch\u00e1vez O (2008) Biological characterization of Trypanosoma cruzi stocks from domestic and sylvatic vectors in Sierra Nevada of Santa Marta, Colombia. Acta Trop 108:26\u201334","journal-title":"Acta Trop"},{"key":"6779_CR64","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0020-7519(01)00153-9","volume":"31","author":"KM Tyler","year":"2001","unstructured":"Tyler KM, Engman DM (2001) The life cycle of Trypanosoma cruzi revisited. Int J Parasitol 31:472\u2013481","journal-title":"Int J Parasitol"},{"key":"6779_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exppara.2006.10.007","volume":"116","author":"NK Verma","year":"2007","unstructured":"Verma NK, Singh G, Dey CS (2007) Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction. Exp Parasitol 116:1\u201313","journal-title":"Exp Parasitol"},{"key":"6779_CR66","unstructured":"WHO (2019) Chagas disease (American trypanosomiasis) fact sheet. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis. Accessed 12\/10\/2019"},{"key":"6779_CR67","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.0711014105","volume":"105","author":"SR Wilkinson","year":"2008","unstructured":"Wilkinson SR, Taylor MC, Horn D, Kelly JM, Cheeseman I (2008) A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc Natl Acad Sci U S A 105:5022\u20135027","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6779_CR68","unstructured":"Zingales B (2017) Trypanosoma cruzi genetic diversity: something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity. Acta Trop S0001-706X(17)30426\u20136"},{"key":"6779_CR69","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1590\/0074-0276140156","volume":"109","author":"B Zingales","year":"2014","unstructured":"Zingales B, Miles MA, Moraes CB, Luquetti A, Guhl F, Schijman AG, Ribeiro I, Drugs for Neglected Disease Initiative, Chagas Clinical Research Platform Meeting (2014) Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity. Mem Inst Oswaldo Cruz 109:828\u2013883","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-020-06779-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:20:08Z","timestamp":1650536408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-020-06779-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["6779"],"URL":"https:\/\/doi.org\/10.1007\/s00436-020-06779-0","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"type":"print","value":"0932-0113"},{"type":"electronic","value":"1432-1955"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}